Otros/as autores/as

Institut Català de la Salut

[Albarrán-Fernández V, Angelats L] Medical Oncology Department, Hospital Clínic, Barcelona, Spain. Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. [Delgado J, Urbano-Ispizua Á] Oncoimmunotherapy Unit, Department of Hematology, Hospital Clínic, Barcelona, Spain. Department of Medicine, University of Barcelona, Barcelona, Spain. [Gros A] Tumor Immunology and Immunotherapy, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Gueda S] Cellular Immunotherapies for Cancer, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain

Vall d'Hebron Barcelona Hospital Campus

Fecha de publicación

2025-04-01T08:49:51Z

2025-04-01T08:49:51Z

2025-01-29



Resumen

Immune cell therapy; Solid tumors


Teràpia cel·lular immune, Tumors sòlids


Terapia cel·lular inmune; Tumores sólidos


Adoptive cell therapy has emerged as a promising approach for treating advanced solid malignancies. Genetic engineering techniques represent an exciting area of research for the development of cellular products with enhanced cytotoxicity, phenotype, and metabolism.

Tipo de documento

Artículo


Versión publicada

Lengua

Inglés

Publicado por

Nature Portfolio

Documentos relacionados

Nature Communications;16

https://doi.org/10.1038/s41467-025-56527-0

Citación recomendada

Esta citación se ha generado automáticamente.

Derechos

Attribution-NonCommercial-NoDerivatives 4.0 International

http://creativecommons.org/licenses/by-nc-nd/4.0/

Este ítem aparece en la(s) siguiente(s) colección(ones)